Vietnam Gene Therapy Market Size, Share, Trends and Forecast by Gene Type, Vector Type, Delivery Method, Application, and Region, 2026-2034

Vietnam Gene Therapy Market Overview:

The Vietnam gene therapy market size reached USD 26.10 Million in 2025. The market is projected to reach USD 75.20 Million by 2034, exhibiting a growth rate (CAGR) of 12.48% during 2026-2034. The market is progressing with enhanced healthcare infrastructure, conducive policies, and increased patient awareness of new treatments. Successful CAR-T cell therapies mark the country's entry into international gene therapy. Increased domestic production and strategic global alliances enhance Vietnam's position as a Southeast Asian hub for cost-effective solutions. Increase in research centers investments and medical knowledge boost innovation in oncology and rare disease therapies and unmet medical needs while solving critical issues, thereby propelling the Vietnam gene therapy market share.

Vietnam Gene Therapy Market Trends:

Advanced Healthcare Infrastructure and Clinical Competences

The Vietnam gene therapy market trends are further dictated by the development of advanced healthcare infrastructure and specialized clinical facilities. Contemporary state-of-the-art laboratories with clean rooms, advanced cell culture systems, and international-standard quality control procedures facilitate the in-country production of gene therapy products, such as cellular therapies. According to the sources, in January 2025, Vietnam successfully treated its first leukemia patient using CAR-T cell therapy at Vinmec Research Institute of Stem Cells and Gene Technology, marking a milestone in the country’s gene therapy initiatives. Moreover, investments in oncology, immunology, and regenerative medicine research centers, as well as the opening of genetic testing centers, biobanks, and personalized medicine projects, have solidified the biotechnology network. Advanced training programs and global collaboration facilitate technical capabilities, allowing for the swift uptake of new treatments. These efforts as a whole broaden clinical capacity and provide patients with access to advanced treatments. Consequently, Vietnam is positioning itself as a regional hub for gene therapy innovation, forming a strong platform for long-term sustainable growth in the Vietnam gene therapy market trends.

Regulatory Evolution and Clinical Trial Facilitation

Progressive regulatory environments are at the forefront of driving the market expansion. The establishment of specialized guidelines for cell and gene therapy has optimized approval procedures without sacrificing strong safety standards. Mechanisms for fast-tracking breakthrough therapies accelerate patient access to treatment in oncology and rare disorders, backed by extensive post-market monitoring. According to the reports, in September 2025, Vietnam successfully treated its first pediatric acute leukemia case using CAR-T cell therapy at the Blood Transfusion and Hematology Hospital in Ho Chi Minh City, pioneering advanced cellular therapy. Furthermore, ethics review boards educated in gene therapy protocols ensure protection of the patient and maintenance of clinical research integrity. Harmonization of regulation and international cooperation make cross-country trials possible, allowing increased participation in worldwide research efforts. These actions not only encourage innovation but also make the development, testing, and clinical use of gene therapies predictable and supportive. Thus, regulatory change is a main force driving market development and the use of newer treatment forms.

Reduction of Cost and Innovation in Local Manufacturing

Cost saving from local manufacturing and advanced manufacturing methods is a key driver of the Vietnam gene therapy market. Production of gene therapy items in-country decreases reliance on imports, reduces cost of treatment, and guarantees quality and effectiveness. Automation, simplified protocols, and robotics enhance scalability and efficiency, improving patient access. Local production also makes it possible to develop region-specific treatments aligned with genetic differences common in Vietnamese and Southeast Asian populations, enhancing clinical success. Public-private collaborations and state-sponsored research efforts promote innovation, developing a cycle of cost-effective gene therapy options that is sustainable. These tactics not only consolidate indigenous supply but also make the nation a competitive force in the regional biotech industry, making way for greater uptake propelling Vietnam gene therapy market growth.

Vietnam Gene Therapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region level for 2026-2034. Our report has categorized the market based on gene type, vector type, delivery method, and application.

Gene Type Insights:

• Antigen
• Cytokine
• Tumor Suppressor
• Suicide Gene
• Deficiency
• Growth Factors
• Receptors
• Others

The report has provided a detailed breakup and analysis of the market based on the gene type. This includes antigen, cytokine, tumor suppressor, suicide gene, deficiency, growth factors, receptors, and others.

Vector Type Insights:

• Viral Vector
  • Adenoviruses
  • Lentiviruses
  • Retroviruses
  • Adeno-associated Virus
  • Herpes Simplex Virus
  • Poxvirus
  • Vaccinia Virus
  • Others
• Non-viral Techniques
  • Naked and Plasmid Vectors
  • Gene Gun
  • Electroporation
  • Lipofection
  • Others

A detailed breakup and analysis of the market based on the vector type have also been provided in the report. This includes viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) and non-viral techniques (naked and plasmid vectors, gene gun, electroporation, lipofection and others).

Delivery Method Insights:

• In-vivo Gene Therapy
• Ex-vivo Gene Therapy

The report has provided a detailed breakup and analysis of the market based on the delivery method. This includes In-vivo gene therapy and ex-vivo gene therapy.

Application Insights:

• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Disease
• Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and others.

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Vietnam Gene Therapy Market Report Coverage:

Key Questions Answered in This Report:

• How has the Vietnam gene therapy market performed so far and how will it perform in the coming years?
• What is the breakup of the Vietnam gene therapy market on the basis of gene type?
• What is the breakup of the Vietnam gene therapy market on the basis of vector type?
• What is the breakup of the Vietnam gene therapy market on the basis of delivery method?
• What is the breakup of the Vietnam gene therapy market on the basis of application?
• What is the breakup of the Vietnam gene therapy market on the basis of region?
• What are the various stages in the value chain of the Vietnam gene therapy market?
• What are the key driving factors and challenges in the Vietnam gene therapy market?
• What is the structure of the Vietnam gene therapy market and who are the key players?
• What is the degree of competition in the Vietnam gene therapy market?

Key Benefits for Stakeholders:

• IMARC's industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Vietnam gene therapy market from 2020-2034.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Vietnam gene therapy market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Vietnam gene therapy industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.